Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 2. Effects of AZD4785 on proliferation and MAPK pathway signaling in KRAS mutant and wild-type cancer cells in vitro. Effects of AZD4785 on proliferation.

Published byΠοδαργη Γούναρης Modified over 5 years ago

Similar presentations

Presentation on theme: "Fig. 2. Effects of AZD4785 on proliferation and MAPK pathway signaling in KRAS mutant and wild-type cancer cells in vitro. Effects of AZD4785 on proliferation."— Presentation transcript:

1 Fig. 2. Effects of AZD4785 on proliferation and MAPK pathway signaling in KRAS mutant and wild-type cancer cells in vitro. Effects of AZD4785 on proliferation and MAPK pathway signaling in KRAS mutant and wild-type cancer cells in vitro. (A) Correlation between IC50 of KRAS down-regulation and inhibition of colony formation by AZD4785 in KRAS wild-type and mutant cell lines. NCI-H1299, NCI-H1793, and Colo201 have an IC50 of colony formation inhibition by AZD4785 of >10 μM. (B) Correlation between IC50 of KRAS and DUSP6 down-regulation by AZD4785 in KRAS wild-type and mutant cell lines. NCI-H1437, NCI-H1299, and Colo201 have an IC50 of DUSP6 down-regulation by AZD4785 of >10 μM. Mean IC50 is shown and generated from a minimum of two independent experiments. (C) Western blot analysis of cell lysates from NCI-H358 or PC9 cells after treatment for 72 hours with a range of doses of AZD4785. Sarah J. Ross et al., Sci Transl Med 2017;9:eaal5253 Published by AAAS

Download ppt "Fig. 2. Effects of AZD4785 on proliferation and MAPK pathway signaling in KRAS mutant and wild-type cancer cells in vitro. Effects of AZD4785 on proliferation."

Similar presentations

Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase by Mayra García, Arik Cooper, Wei Shi, William Bornmann, Ricardo Carrion,

Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase by Mayra García, Arik Cooper, Wei Shi, William Bornmann, Ricardo Carrion,
SCLCs and LCNECs are sensitive to PARP inhibition in vitro.

SCLCs and LCNECs are sensitive to PARP inhibition in vitro.
Differentiation of AZD4785 from MAPK pathway inhibitors in vitro

Differentiation of AZD4785 from MAPK pathway inhibitors in vitro
Fig. 1. Potent and selective down-regulation of KRAS mRNA and protein by AZD4785 in vitro and in vivo. Potent and selective down-regulation of KRAS mRNA.

Fig. 1. Potent and selective down-regulation of KRAS mRNA and protein by AZD4785 in vitro and in vivo. Potent and selective down-regulation of KRAS mRNA.
Fig. 3. Cytokines trigger proliferation and block differentiation of perivascular adipocytes. Cytokines trigger proliferation and block differentiation.

Fig. 3. Cytokines trigger proliferation and block differentiation of perivascular adipocytes. Cytokines trigger proliferation and block differentiation.
Fig. 1. The cell-intrinsic fibroblast circadian proteome contains numerous cytoskeletal regulators. The cell-intrinsic fibroblast circadian proteome contains.

Fig. 1. The cell-intrinsic fibroblast circadian proteome contains numerous cytoskeletal regulators. The cell-intrinsic fibroblast circadian proteome contains.
Fig. 5. Circulating PPi concentration does not correlate with severity of calcification phenotype in mice. Circulating PPi concentration does not correlate.

Fig. 5. Circulating PPi concentration does not correlate with severity of calcification phenotype in mice. Circulating PPi concentration does not correlate.
A FOXO3a-BIM cascade mediates sensitivity to PARP and MEK inhibition

A FOXO3a-BIM cascade mediates sensitivity to PARP and MEK inhibition
BET inhibition and depletion repress the expression of BRCA1 and RAD51

BET inhibition and depletion repress the expression of BRCA1 and RAD51
Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.

Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.
β-ARs signal cooperatively with mutant EGFR and inactivate LKB1

β-ARs signal cooperatively with mutant EGFR and inactivate LKB1
Fig. 2. In vitro profiling of tEV markers on cell line–derived EVs.

Fig. 2. In vitro profiling of tEV markers on cell line–derived EVs.
Fig. 6. Treatment with a DLK inhibitor is neuroprotective and reverses stress-induced gene expression changes. Treatment with a DLK inhibitor is neuroprotective.

Fig. 6. Treatment with a DLK inhibitor is neuroprotective and reverses stress-induced gene expression changes. Treatment with a DLK inhibitor is neuroprotective.
Fig. 4. Functional annotation of VUS in EGFR.

Fig. 4. Functional annotation of VUS in EGFR.
Fig. 2. Mutant KRAS mediates resistance to PARPi and sensitivity to PARPi and MEKi Mutant KRAS mediates resistance to PARPi and sensitivity to PARPi and.

Fig. 2. Mutant KRAS mediates resistance to PARPi and sensitivity to PARPi and MEKi Mutant KRAS mediates resistance to PARPi and sensitivity to PARPi and.
Synergistic effect of S63845 with lapatinib, trastuzumab, or docetaxel

Synergistic effect of S63845 with lapatinib, trastuzumab, or docetaxel
Fig. 6. Pathway analysis of CMLD

Fig. 6. Pathway analysis of CMLD
Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.

Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.
Fig. 2. GPC3 expression in normal and tumor tissues.

Fig. 2. GPC3 expression in normal and tumor tissues.
Bio-AMS enhances the activity of rifampicin and ethambutol in vitro

Bio-AMS enhances the activity of rifampicin and ethambutol in vitro

Similar presentations

Ads by Google